Challenges and opportunities in bringing new medications to market for pediatric patients.
Upadhyaya
Himanshu P
HP
Drs. Upadhyaya and Allen are with Eli Lilly & Company. Dr. Gault is with Abbott Laboratories. Electronic address: upadhyayahp@Lilly.com.
Gault
Laura
L
Drs. Upadhyaya and Allen are with Eli Lilly & Company. Dr. Gault is with Abbott Laboratories.
Allen
Albert J
AJ
Drs. Upadhyaya and Allen are with Eli Lilly & Company. Dr. Gault is with Abbott Laboratories.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence / Q000379:methods; D003431:Cross-Cultural Comparison; D017277:Drug Approval / Q000331:legislation & jurisprudence / Q000379:methods*; D055808:Drug Discovery / Q000331:legislation & jurisprudence / Q000379:methods; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence / Q000592:standards
D011619:Psychotropic Drugs